158 related articles for article (PubMed ID: 3953354)
1. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone.
Anderson JL; Askins JC; Gilbert EM; Menlove RL; Lutz JR
Am Heart J; 1986 Mar; 111(3):466-74. PubMed ID: 3953354
[TBL] [Abstract][Full Text] [Related]
2. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
3. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group.
Feneck RO
J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):554-62. PubMed ID: 1421066
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.
Anderson JL; Baim DS; Fein SA; Goldstein RA; LeJemtel TH; Likoff MJ
J Am Coll Cardiol; 1987 Apr; 9(4):711-22. PubMed ID: 3549837
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States.
Anderson JL
Am Heart J; 1991 Jun; 121(6 Pt 2):1956-64. PubMed ID: 2035427
[TBL] [Abstract][Full Text] [Related]
6. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
[TBL] [Abstract][Full Text] [Related]
8. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
Varriale P; Ramaprasad S
Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
[TBL] [Abstract][Full Text] [Related]
9. Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias.
Holmes JR; Kubo SH; Cody RJ; Kligfield P
Am Heart J; 1985 Oct; 110(4):800-6. PubMed ID: 4050652
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery.
Butterworth JF; Hines RL; Royster RL; James RL
Anesth Analg; 1995 Oct; 81(4):783-92. PubMed ID: 7574011
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
Cesario D; Clark J; Maisel A
Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
[TBL] [Abstract][Full Text] [Related]
13. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents.
Tisdale JE; Patel R; Webb CR; Borzak S; Zarowitz BJ
Prog Cardiovasc Dis; 1995; 38(2):167-80. PubMed ID: 7568905
[TBL] [Abstract][Full Text] [Related]
15. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Kobayashi S; Susa T; Tanaka T; Murakami W; Fukuta S; Okuda S; Doi M; Wada Y; Nao T; Yamada J; Okamura T; Yano M; Matsuzaki M
Circ J; 2012; 76(7):1646-53. PubMed ID: 22481100
[TBL] [Abstract][Full Text] [Related]
16. Effects of a twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition.
Klocke RK; Mager G; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1965-73. PubMed ID: 2035428
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH
Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
[TBL] [Abstract][Full Text] [Related]
19. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
